Neuropeptides and Alzheimer's disease

Author： Gottfries C.-G.   Frederiksen S.O.   Heilig M.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.4, 1995-12, pp. : 491-500

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Galantamine for Alzheimer's disease

By Prvulovic David   Hampel Harald   Pantel Johannes  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 345-354

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory processes in Alzheimer's disease

By McGeer E.G.   McGeer P.L.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 5, 2003-08 ,pp. : 741-749

Elsevier

Access to resources Recommend Favorite

Treatment strategies in Alzheimer's disease

By Levy R.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 204-205

Elsevier

Access to resources Recommend Favorite

Combination Therapy for Alzheimer's Disease

By Patel Laxeshkumar   Grossberg George T.  

Drugs & Aging, Vol. 28, Iss. 7, 2011-07 ,pp. : 539-546

Adis International

Access to resources Recommend Favorite

The Biochemistry of Alzheimer's Disease

By Stege G.J.J.   Bosman G.J.C.G.M.  

Drugs & Aging, Vol. 14, Iss. 6, 1999-06 ,pp. : 437-446

Adis International

Access to resources Recommend Favorite